Guest guest Posted November 17, 2008 Report Share Posted November 17, 2008 Very Important 3 New Studies on Mercury and Autism This update is from Dr. Mark Geier & Geier This is a status update regarding the continuing avalanche of ever increasing numbers of studies that are emphatically supporting and extending the theory that mercury exposure, and particularly, mercury exposure from Thimerosal-containing vaccines plays a significant role in causing autism and other neurodevelopmental disorders. First, and perhaps most importantly, is the first epidemiological peer-reviewed study on US children (other than our own extensive body of peer-reviewed studies) to show a statistically significant increased risk for neurodevelopmental disorders following exposure to increasing doses of mercury from Thimerosal-containing childhood vaccines. This study is attached to this email saved as Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years1 in Adobe Acrobat Format. http://www.sarnet.org/lib/hepBdds.pdf This study was published in the journal of Toxicological and Environmental Chemistry by newly published researchers on Thimerosal from the School of Public Health, Stony Brook University Medical Center, Health Sciences Center, State University of New York at Stony Brook. These researchers reported their, " study investigated the association between the hepatitis B triple serieis vaccination in children age 1-9 years and developmental disability, proxied by parental report of early intervention or special education services (EIS) in the 1999-2000 National Health and Nutrition Examination Survey (NHANES). " Further, they stated, " while this study uses EIS as a proxy for developmental disability in general, but not specifically autism, autism mertis consideration because it is a develpmental disorder with recent notable impacts on EIS. The number of children receiving special education services for autism increased 500% from 1991/92 to 1998/99 (CDC 2007b). " Finally, " vaccination with hepatitis B triple series vaccine during the time period vaccines were manufactured with Thimerosal exposed newborns and infants to ethylHg (CDC 2000). By using NHANES 1999-2000 data for children age 1-9 years of age, children who were candidates for the Thimerosal-containing triple series hepatitis B vaccine were included in the study sample. The eldest children who received the triple series hepatitis B vaccine would have been vaccinated during 1991, the first year that the thimerosal-containing vaccine was recommended for newborns (CDC 1991), while the youngest children would have been vaccinated during 1999, the last full year of known access to only Thimerosal-containing vaccines (CDC 2000). " These researchers reported, " The study sample data set was obtained from the National Health and Nutrition Examination Survey (NHANES) 1999-2000 data set, which included a total of 9965 participants - both adults and children. NHANES is a cross-sectional, random household survey of the civilian population based on a complex probability sampling design. The survey is a continous program of the National Center for Health Statistics (CHS), which is a part of the Centers for Disease Control and Prevention (CDC). NHANES provides information about the distribution of health problems and risk factors that contribute to poor health outcomes. In addition to conducting interview of almost 10,000 persons per year, the survey examines a nationally representative of about 5000 persons each year. The sample for the survey is selected to represent the US population of all ages...Epidemiologists and health science researchers use NHANES data to generate findings that provide guidance for public health policy development and health program design. NHANES data provide researchers with important clues to the causes of disease (CDC 2004a). " In the present study, the researchers examined the status of hepatitis B vaccination among the participants examined. A total of 1,824 observations included children aged 1-9 years of age and with parents who answered either 'yes' or 'no' to the survey questions, " Does your child receive Special Education or Early Intervention Services? " Participants were evaluated that had either received a full course of hepatitis B vaccination or were unvaccinated, and a number of other variables were considered in evaluating the children. The researchers conducted statistical analyses using SAS, and analytical methods employed were those previously suggested by the NCHS of the CDC. These researchers reported regarding their findings, " the odds of receiving EIS were approximately nine times as great for vaccination boys (n=46) as for unvaccinated boys (n=7) after adjustment for confounders. " The researchers strongly concluded, " This study contributes to answering an unresolved question of the Institute of Medicine's (IOM's) 2001 Immunization Safety Review (IOM 2001) as well as the same question not addressed by the IOM's 2004 review (IOM 2004), namely, whether there is an association between thimerosal-containing vaccines and neurodevelopmental disorders, in general (McCormick 2004). As did the IOM in their 2004 study, et al. (2004) more specifically concluded that studies did not demonstrate a link between thimerosal-containing vaccines and autism, and cited supporting evidence from cohort studies conducted in the United Kingdom (UK), Denmark, and Sweden. However, unlike the United States, past (CDC 1991; CDC 1998) and present (CDC 2006b), these countries' vaccination schedules do not recommend universal vaccination of newborns with the Hepatitis B vaccine (ECDC 2006a, . Sweden recommends that Hepatitis B be given at birth only to infants of mothers positive for Hepatitis B (ECDC 2006c). In 1998, the UK vaccinated newborns with the Hepatitis B vaccine, but again, only to infants of mothers positive for Hepatitis B (Ovetchkine and Reinert 1998). Thus, it is reasonable to question the applicability of findings from the UK, Denmark and Sweden studies to the US immunized pediatric population. This study found statistically significant evidence of an association between the thimerosal-containing Hepatitis B triple series vaccine and EIS, a proxy for developmental disability. Although Hepatitis B vaccines administered to children in United States no longer contain thimerosal, those administered to children in developing countries without the means to prepare single dose vials do contain thimerosal (WHO 2004, 2006). Moreover, influenza vaccines distributed in United States do contain thimerosal (CDC 2006a). Thus, children's previous and potential future exposure to thimerosal remains an important public health concern. Future research should (1) examine how public health efforts might better identify harmful exposures and susceptible children; (2) institute effective protective and quality improvement measures; (3) conduct cost-benefit analyses that more comprehensively consider the costs and more accurately assess the risks for the US population of children, especially subpopulations of susceptible children. " Second, a study, " Vaccine Preservative, Thimerosal, Causes Wide-Spread Neurodevelopmental Disturbances in Young Rats " by Researchers from University of Warsaw, Dpartment of Pharmacology, Institute of of Psychiatry and Neurology, including the Marie Curie Chair, European Union, was presented at the International Conference on Autism and Vaccinations: Is There a Link? at the University of Warsaw (October 25-26, 2008). http://www.sarnet.org/lib/thimrats.pdf We attended this conference and had meetings with many of the researchers from various European countries (including Poland, Germany, England, and France), as well as US researchers, presenting evidence of the role of mercury, and in particular, Thimerosal, as a causal factor for autistic disorders. A copy of an abstract from the above cited study published in the conference proceedings is attached to this email saved as Vaccine Preservative Thimerosal Causes Wide Spread Neurodevelopmental Disturbances in Young Rats1.pdf in Adobe Acrobat Format. These researchers described, " in this study, we examined the potential neurotoxic effects of Thimerosal, which was administered to rat pups i.m. on postnatal days 7, 9, 11, 14 in four equal doses, mimicking infants' immunization scheme. We monitored mercury distribution to different organs, general animal development, conducted several behavioral tests and examined the brains for neuropthaological changes. The following evahvioral tests were chosen to monitor alterations of rats' beavior in the context of beahviors observed in Autism Spectrum Disorders: motor acitivity in the open field, pain reaction and pain sensitivity (hot plate), sociation interactions, learning and memory (water maze). Brain hisopathological obsercations (H & E and immunohistochemsitry - GFAP, neurofilaments, synaptophysins) were carried out as well. " These researchers observed, " mercury from postnatally administered Thimerosal accumulated in several organs and remained there in large amounts for at least 30 days...The brain contained 13-18% of the amount of mercury originally injected i.m., calculated per tissue/body weight. Mercury remained in the brain in significant amounts at least for 30 days after Thimerosal injection. " Further, " the animals exposed postnatally to Thimerosal had noticeably impaired locomotor acitivity. They were significantly slower in the open field and in water maze, and exhibited more anxiety than control rats. They had markedly impaired pain reactions, measured in hot plate test and their social interactions were disturbed. " Finally, " the brain weights of Thimerosal injected rats were signficantly reduced and there were wide spread morphological and pathological changes in several brain regioins, particularly in the cerebral cortex, striatum, amygdale, hippocampus and the cerebellum. These researchers concluded, " the multiple behavioral and neuropathological changes observed in young rats exposed postnally to Thimerosal confirm that this vaccine preservative is neurotoxic to the developing mammalian organisms. As such it could be responsible, in part, for the brain and other organs damage in children, exposed to it in many vaccines. " Third, we have attached to this email a copy of a new peer-reviewed study (in press) from the journal of Environmental Health saved as Feeding Mice with Diets Containing Low Dose Methylmercury-Fish & Adverse Effects1 in Adobe Acrobat Format. http://www.sarnet.org/lib/mercmice.pdf The importance of this study is that it examines very, very low dose exposure to postnatal methylmercury dosing and its effects on behavioral testing, brain and other organ pathology (as measured by gene expression), and mitochondrial dysfucntion in mice. The dosing regiments resulted in brain levels of mercury as follow: Low Dose = 5 parts-per-billion (equal to the amount of mercury presumed to present in Hornig et al.'s mouse model of Thimerosal induced autism, and 10-fold lower than that present in the brain of Burbacher et al.'s infant monkeys dosed with Thimerosal-containing vaccines mimicking the US childhood vaccine schedule. Medium Dose = 63 parts-per-billion (about equal to the brain mercury level present in Burbacher et al.'s Thimerosal-exposed infant monkeys) High Dose = 299 parts-per-billion (about 5-fold higher to the mercury level present in the brain of Burbacher et al.'s Thimerosal-exposed infant monkeys, and within a few fold of the brain mercury level of Burbacher et al.'s methylmercury exposed infant monkeys). These researchers observed that mercury expoure at all the levels examined induced significant differences in gene expression related to mitochondrial metabolism, oxidiative stress, detoxication processes, and cellular apoptosis. It was observed in the hippocampus region of the brain (a key damaged area in autism) that the moderate dose of mercury exposure significantly induced up-regulation of genes associated with oxidative stress, detoxification processes, and cellular apoptosis (i.e. cell programmed death). Further, these researchers observed that significant mitochondrial dysfunction was observed even in the low dose exposure group, and that the type of damage that occured involved cytochrome c oxidase (a key component of electron transport in the mitochondrial), which previously reported to be abnormal in many children diagnosed with autistic disorders. Finally, these researchers observed that in the low and moderate dose groups significant negative impacts were observed in behaviors as measured in a large battery of beavhioral measurements. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 17, 2008 Report Share Posted November 17, 2008 The MERCURY DEBATE.. has long since NOT been a debate. Those that wish to believe that scientific evidence proves nothing.. can thing that if they may.. so keep your insults to yourseves * to the cynic's and critics * . We've known for quite some time that this team of Doctos has been working hard on the effects of Thimerosal. I do believe they deserve a round of applause and a 'Thank You' from all.. even those who have forgotton how to thank people that are helping their kids in whatever way they can. I do think that we all must remember that there is no blood test for Autism/ASD;s. Criteria has been sharpened and as awareness arose so did the numbers.. but the arose so high that it's literally rediculous. Some have mocked me for using the terms " EPIDEMIC and PANDEMIC " ... of course Autism is not a plague. And while I certainly understand that some high functioning kids are doing great.. I also know that some parents need to understand there are kids with Autism that ARE locked up, that ARE biting and hitting themselves day and night.. there are hundreds of thousands with improper educations. I think it's Time the Dad and Son Grier family tem goes before congress.. but with a new administrations. Should be interesting to see.. especially now that the word " Autism ' is known well by the president elect as he debated over it.. It's a season for change and its all we can hope for. I hope all is well with everyone's educational program. If need be you can contact me at Peace4kids@.... Peace be with you, E. , Sr. Dir/Advocate The Office of Advocacy for Autistic Childen ===================== Posted through Grouply, the better way to access your Yahoo Groups like this one. http://www.grouply.com/?code=post Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.